
Send us Fan Mail What does the stock market have to do with curing type 1 diabetes? Actually...a lot. In this episode of the Diabetes Nerd Podcast, my friend Julia Flaherty joins me to pull back the curtain on the business side of diabetes research. We talk about how biotech companies raise money, why investors get excited about clinical trial results, what happens when a company gets acquired, and why so many people living with T1D are becoming shareholders themselves. If you've ever wondere...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Carbohydrate Science You Never Knew

The Diabetes App That Fills the Gaps Left by Your CGM & Pump

T1D Scientist Explains Why Curing 12 Patients Isn't Enough

T1D Scientist Explains Why Eledon’s Therapy Isn’t the Universal Cure
Free AI-powered recaps of Diabetes Nerd and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.